What is Muscular Dystrophy?

The muscular dystrophies represent disorders of progressive muscular degeneration and weakness. As a group, they exhibit clinical heterogeneity that reflects diverse molecular mechanisms responsible for them and range from congenital to adulthood onset. All are genetic, but different types reflect different genes that are implicated in the pathogenesis. Recent advances in the field resulted in improved methods of diagnosis and the development of novel therapeutic approaches.

The word dystrophy has its roots in two ancient Greek words: “dys” which means abnormal or faulty, and “trophe” which means food or nourishment. The reason for such designation, it because it was thought that there was a defect in the nourishment of the muscle, in the same way, that a person who does not eat the correct food will not grow adequately.

Image Credit: Dan76 / Shutterstock
Image Credit: Dan76 / Shutterstock

Pathophysiology of muscular dystrophies

Skeletal muscle represents a highly specialized organ system which in humans evolved for locomotion and energy metabolism. The functional unit of the skeletal muscle is myofiber, which can be defined as a multinucleated tubular structure created by the fusion of multiple mononucleated muscle cells or myoblasts.

Various structural and regulatory proteins are required in order to maintain the proper function and integrity of the muscle. Hence mutations of the genes involved in synthesis and regulation of those proteins can be responsible for the disruption of the muscle tissue. Such progressive muscle tissue damage can result in weakness and sometimes even loss of muscle bulk or replacement of normal muscle structure by scar tissue or fat.

In certain forms of muscular dystrophy, functional loss of proteins that are part of the dystrophin complex can weaken the plasma membrane of the muscle cells to the extent where even normal exercise tears the membrane. That results in the influx of extracellular ions (such as sodium and calcium) which destroy sarcoplasmic function; hence the affected muscle tissue loses contractile cells.

The extracellular matrix of the muscle can be viewed as a meshwork of collagen, glycoproteins and proteoglycans, and provides an attachment and signaling scaffold for myofibers. Mutations in several genes encoding the structural components of this matrix are responsible for congenital muscular dystrophies. Loss of integrin-mediated linkage between the cytoskeleton and the extracellular matrix is another important step in the development of muscular dystrophy.


A careful family history and the physical examination still represent a pivotal step in establishing a correct diagnosis, although a myriad of different laboratory test are employed in order to confirm the suspicion. Genetic testing often represents an important approach not only for diagnosing muscular dystrophies, but also to detect potential carriers.

The most important tools to address potential differential diagnostic issues are the determination of creatine kinase (CK) levels in order to see if there is a persistent increase of CK in plasma samples, magnetic resonance imaging (MRI) of the brain, nerve conduction velocity studies with repetitive stimulation to recognize abnormalities of neuromuscular transmission, muscle biopsy, as well as specific metabolic or genetic testing.

The diagnosis of congenital muscular dystrophies requires expertise in multiple specialties (such as neurology, pathology, neuroradiology, and genetics) available in only a few centers worldwide with sufficient experience to recognize a plethora of different subtypes. In addition, ECG and pulmonary function tests are often indispensable in the postoperative care of dystrophic patients.

The advent of molecular diagnosis is essential for genetic and prenatal counseling, phenotype-genotype correlations, as well as for adequate management and prognosis for muscle dystrophies. Early identification of causative mutations will enable clinicians to take proactive measures to halt or even reverse muscle degeneration.

Last Updated: Nov 8, 2022

Dr. Tomislav Meštrović

Written by

Dr. Tomislav Meštrović

Dr. Tomislav Meštrović is a medical doctor (MD) with a Ph.D. in biomedical and health sciences, specialist in the field of clinical microbiology, and an Assistant Professor at Croatia's youngest university - University North. In addition to his interest in clinical, research and lecturing activities, his immense passion for medical writing and scientific communication goes back to his student days. He enjoys contributing back to the community. In his spare time, Tomislav is a movie buff and an avid traveler.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Meštrović, Tomislav. (2022, November 08). What is Muscular Dystrophy?. News-Medical. Retrieved on June 25, 2024 from https://www.news-medical.net/health/What-is-Muscular-Dystrophy.aspx.

  • MLA

    Meštrović, Tomislav. "What is Muscular Dystrophy?". News-Medical. 25 June 2024. <https://www.news-medical.net/health/What-is-Muscular-Dystrophy.aspx>.

  • Chicago

    Meštrović, Tomislav. "What is Muscular Dystrophy?". News-Medical. https://www.news-medical.net/health/What-is-Muscular-Dystrophy.aspx. (accessed June 25, 2024).

  • Harvard

    Meštrović, Tomislav. 2022. What is Muscular Dystrophy?. News-Medical, viewed 25 June 2024, https://www.news-medical.net/health/What-is-Muscular-Dystrophy.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.